# Roswell Park Comprehensive Cancer Center

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/roswell-park-comprehensive-cancer-center/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 70.5 |
| Citations | 4,013,753 |
| City | Buffalo |
| Country | US |
| Description | Roswell Park Comprehensive Cancer Center is a research organisation in Buffalo, US. OpenAlex records 33,239 works and 4,013,753 citations for it. 5,644 researchers list it as their most recent affiliation. |
| Homepage | https://www.roswellpark.org/ |
| OpenAlex ID | https://openalex.org/I1292894508 |
| Region | New York |
| Researchers | 5,644 |
| ROR ID | https://ror.org/0499dwk57 |
| Type | facility |
| Works | 33,239 |

## University papers

Showing 12 of 144.

- [Integrated genomic analyses of ovarian carcinoma](https://scholariq.org/papers/integrated-genomic-analyses-of-ovarian-carcinoma/)
- [Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer](https://scholariq.org/papers/safety-and-activity-of-anti-pd-l1-antibody-in-patients-with-advanced-cancer/)
- [The GTEx Consortium atlas of genetic regulatory effects across human tissues](https://scholariq.org/papers/the-gtex-consortium-atlas-of-genetic-regulatory-effects-across-human-tissues/)
- [Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma](https://scholariq.org/papers/nivolumab-versus-everolimus-in-advanced-renal-cell-carcinoma/)
- [The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans](https://scholariq.org/papers/the-genotype-tissue-expression-gtex-pilot-analysis-multitissue-gene-regulation/)
- [Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma](https://scholariq.org/papers/nivolumab-plus-ipilimumab-versus-sunitinib-in-advanced-renal-cell-carcinoma/)
- [Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline](https://scholariq.org/papers/management-of-immune-related-adverse-events-in-patients-treated-with-immune/)
- [Genomic Classification of Cutaneous Melanoma](https://scholariq.org/papers/genomic-classification-of-cutaneous-melanoma/)
- [International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma](https://scholariq.org/papers/international-myeloma-working-group-consensus-criteria-for-response-and-minimal/)
- [Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia](https://scholariq.org/papers/efficacy-and-toxicity-management-of-19-28z-car-t-cell-therapy-in-b-cell-acute/)
- [Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer](https://scholariq.org/papers/incorporation-of-bevacizumab-in-the-primary-treatment-of-ovarian-cancer/)
- [Tobacco smoke and involuntary smoking](https://scholariq.org/papers/tobacco-smoke-and-involuntary-smoking/)

## University researchers

- [Andrew Hyland](https://scholariq.org/researchers/andrew-hyland/)
- [Khurshid A. Guru](https://scholariq.org/researchers/khurshid-a-guru/)
- [Qiang Li](https://scholariq.org/researchers/qiang-li/)

## University top topics

Showing 8 of 25.

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Smoking Behavior and Cessation](https://scholariq.org/topics/smoking-behavior-and-cessation/)
- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.